UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer

Frontiers in oncology, 2023-03, Vol.13, p.1063636-1063636

2023

Volltextzugriff (PDF)

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Leukemia, 2018-09, Vol.32 (9), p.1948-1957

2018

Volltextzugriff (PDF)

Autoimmune cytopenias in chronic lymphocytic leukemia

American journal of hematology, 2014-11, Vol.89 (11), p.1055-1062

2014

Volltextzugriff (PDF)

Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers

Nature medicine, 2014-06, Vol.20 (6), p.599-606

2014

Volltextzugriff (PDF)

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

Clinical cancer research, 2017-06, Vol.23 (11), p.2891-2904

2017

Volltextzugriff (PDF)

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome

Haematologica (Roma), 2022-04, Vol.107 (4), p.921-932

2022

Volltextzugriff (PDF)

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

Blood, 2019-01, Vol.133 (2), p.156-167

2019

Volltextzugriff (PDF)

Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma

Haematologica (Roma), 2021-01, Vol.106 (1), p.185-195

2021

Volltextzugriff (PDF)

Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma

Oncotarget, 2016-03, Vol.7 (12), p.14814-14830

2016

Volltextzugriff (PDF)

Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma

Haematologica (Roma), 2019-02, Vol.104 (2), p.e72-e76

2019

Volltextzugriff (PDF)

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

Blood, 2009-12, Vol.114 (25), p.e20-e26

2009

Volltextzugriff (PDF)

Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7626

2022

Volltextzugriff (PDF)

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Blood, 2011-01, Vol.117 (2), p.553-562

2011

Volltextzugriff (PDF)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?

Frontiers in oncology, 2020-10, Vol.10, p.593383-593383

2020

Volltextzugriff (PDF)

LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?

Non-coding RNA, 2020-07, Vol.6 (3), p.26

2020

Volltextzugriff (PDF)

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma

Oncotarget, 2017-12, Vol.8 (63), p.106527-106537

2017

Volltextzugriff (PDF)

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma

Oncotarget, 2016-03, Vol.7 (11), p.12731-12747

2016

Volltextzugriff (PDF)

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Blood, 2016-01, Vol.127 (2), p.221-232

2016

Volltextzugriff (PDF)

Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

Haematologica (Roma), 2023-01, Vol.108 (1), p.219-233

2023

Volltextzugriff (PDF)

Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma

Clinical cancer research, 2021-12, Vol.27 (23), p.6479-6490

2021

Volltextzugriff (PDF)

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Haematologica (Roma), 2024-07

2024

Volltextzugriff (PDF)

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities

Cancers, 2021-06, Vol.13 (13), p.3213

2021

Volltextzugriff (PDF)

Targeting Notch as a Therapeutic Approach for Human Malignancies

Current pharmaceutical design, 2017-01, Vol.23 (1), p.108-1

2017

Volltextzugriff (PDF)

1 – 25 von 687

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(647)
Mit Volltextzugriff
(604)

Publikationsform

Sprache

Englisch
(684)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Autoimmune cytopenias in chronic lymphocytic leukemia

Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma

Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma

Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?

LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities

Targeting Notch as a Therapeutic Approach for Human Malignancies

Suchergebnisse filtern